These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2536929)

  • 1. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.
    Parthasarathy S; Wieland E; Steinberg D
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1046-50. PubMed ID: 2536929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of 15-lipoxygenase by low density lipoprotein in vascular endothelial cells. Relationship to the oxidative modification of low density lipoprotein.
    Derian CK; Lewis DF
    Prostaglandins Leukot Essent Fatty Acids; 1992 Jan; 45(1):49-57. PubMed ID: 1546066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular oxidative modification of low density lipoprotein does not require lipoxygenases.
    Sparrow CP; Olszewski J
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):128-31. PubMed ID: 1729678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway.
    McNally AK; Chisolm GM; Morel DW; Cathcart MK
    J Immunol; 1990 Jul; 145(1):254-9. PubMed ID: 2162888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex.
    Cathcart MK; McNally AK; Chisolm GM
    J Lipid Res; 1991 Jan; 32(1):63-70. PubMed ID: 1901344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative modification of low density lipoproteins by human polymorphonuclear leukocytes.
    Wieland E; Brandes A; Armstrong VW; Oellerich M
    Eur J Clin Chem Clin Biochem; 1993 Nov; 31(11):725-31. PubMed ID: 8305616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Lipoxygenase is not essential in macrophage-mediated oxidation of low-density lipoprotein.
    Jessup W; Darley-Usmar V; O'Leary V; Bedwell S
    Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):163-9. PubMed ID: 1883327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification.
    Sparrow CP; Parthasarathy S; Steinberg D
    J Lipid Res; 1988 Jun; 29(6):745-53. PubMed ID: 3139813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism.
    Mukhopadhyay CK; Ehrenwald E; Fox PL
    J Biol Chem; 1996 Jun; 271(25):14773-8. PubMed ID: 8663020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages.
    Rankin SM; Parthasarathy S; Steinberg D
    J Lipid Res; 1991 Mar; 32(3):449-56. PubMed ID: 1906087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative modification of LDL: comparison between cell-mediated and copper-mediated modification.
    Parthasarathy S; Fong LG; Quinn MT; Steinberg D
    Eur Heart J; 1990 Aug; 11 Suppl E():83-7. PubMed ID: 2121485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative modification of low-density lipoproteins by mesangial cells.
    Keane WF; O'Donnell MP; Kasiske BL; Kim Y
    J Am Soc Nephrol; 1993 Aug; 4(2):187-94. PubMed ID: 8400082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms involved in the in vitro modification of low density lipoprotein by human umbilical vein endothelial cells and copper ions.
    Cominacini L; Garbin U; De Santis A; Campagnola M; Davoli A; Pasini AF; Faccini G; Pasqualini E; Bertozzo L; Micciolo R; Pastorino AM; Lo Cascio V
    J Lipid Mediat Cell Signal; 1996 Jan; 13(1):19-33. PubMed ID: 8821808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceruloplasmin copper induces oxidant damage by a redox process utilizing cell-derived superoxide as reductant.
    Mukhopadhyay CK; Fox PL
    Biochemistry; 1998 Oct; 37(40):14222-9. PubMed ID: 9760260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms.
    Heinecke JW; Kawamura M; Suzuki L; Chait A
    J Lipid Res; 1993 Dec; 34(12):2051-61. PubMed ID: 8301226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of superoxide in endothelial-cell modification of low-density lipoproteins.
    Steinbrecher UP
    Biochim Biophys Acta; 1988 Mar; 959(1):20-30. PubMed ID: 2830901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelial cells and their products in the modification of low-density lipoproteins.
    van Hinsbergh VW; Scheffer M; Havekes L; Kempen HJ
    Biochim Biophys Acta; 1986 Aug; 878(1):49-64. PubMed ID: 3730414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does superoxide radical have a role in macrophage-mediated oxidative modification of LDL?
    Jessup W; Simpson JA; Dean RT
    Atherosclerosis; 1993 Feb; 99(1):107-20. PubMed ID: 8384855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation of human low-density lipoprotein by soybean 15-lipoxygenase in combination with copper (II) or met-myoglobin.
    O'Leary VJ; Graham A; Stone D; Darley-Usmar VM
    Free Radic Biol Med; 1996; 20(4):525-32. PubMed ID: 8904293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide enhances oxidative modification of low density lipoprotein by copper ions, endothelial and smooth muscle cells.
    Maziere C; Conte MA; Dantin F; Maziere JC
    Atherosclerosis; 1999 Mar; 143(1):75-80. PubMed ID: 10208481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.